Vimarsana
Biggest News Aggregation in the World

Mm 120 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mm 120. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mm 120 Today - Breaking & Trending Today

Psychiatry Month in Review: March 2024 - Vimarsana News

Psychiatry Month in Review: March 2024

Published: April 1, 2024

This March 2024 psychiatry month in review highlights positive phase 2b and phase 2a data for drugs targeting treatment-resistant depression, generalized anxiety disorder, and PTSD.

Source: hcplive.com
Related Topics:
Beckley PsytechDaniel KarlinViktoriya KarakcheyevaEmily BernsteinCenter At George Washington UniversityAtai Life SciencesRittenhouse Psychiatric AssociatesDrug AdministrationInternational WomenWith MarchAnxiety BreakthroughGeneralized AnxietyClinically Meaningful PhaseLife SciencesWell Being CenterGeorge Washington UniversityWomen WorkingFda Breakthrough DesignationMm 120Bpl 003Bpl 003 For Treatment Resistant DepressionBnc210 Bnc210 For PtsdWomen BurnoutWomen Healthcare Worker Burnout
Daniel Karlin, MD: Topline MM-120 Data for Generalized Anxiety Disorder - Vimarsana News

Daniel Karlin, MD: Topline MM-120 Data for Generalized Anxiety Disorder

Published: December 15, 2023

A phase 2b clinical trial met its primary endpoint with positive topline results, showing MM-120 (lysergide d-tartrate) can reduce symptoms of generalized anxiety disorder, reflected in the Hamilton Anxiety rating scale scores.

Source: hcplive.com
Related Topics:
United StatesDaniel KarlinMedicine Mindmed IncUniversity Of Colorado School MedicineDrug AdministrationUs Preventive Services TaskMind MedicineInvestigational New Drug ApplicationSegal TrialsHamilton Anxiety Rating ScaleClinical Global ImpressionsMindmed Chief Officer Daniel KarlinColorado SchoolServices Task ForceTopline DataGeneralized Anxiety DisorderLsd TreatmentMm 120Lysergided Tartrate Phase 2b Trial